Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on March 24, 2026

Mar. 24, 2026

ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39

Indeterminate GlobeNewswire

Mar. 24, 2026

VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs

Indeterminate GlobeNewswire

Mar. 24, 2026

Beacon Behavioral Partners Welcomes Novus Neurology and SunCoast Psychiatry

Indeterminate GlobeNewswire

Mar. 24, 2026

Press Release Biocartis NV: Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures

Indeterminate GlobeNewswire

Mar. 24, 2026

Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis

Indeterminate GlobeNewswire

Mar. 24, 2026

Callio Therapeutics Doses First Patient in Phase I Clinical Trial of Dual-Payload ADC CLIO-8221 in Advanced HER2-Expressing Solid Tumors

Indeterminate GlobeNewswire

Mar. 24, 2026

Addgene and Plasmidsaurus Announce Strategic Partnership to Scale Sequencing for Leading Plasmid Repository

Indeterminate GlobeNewswire

Mar. 24, 2026

INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.

Indeterminate GlobeNewswire

Mar. 24, 2026

Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials

Indeterminate GlobeNewswire

Mar. 24, 2026

IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026

Indeterminate GlobeNewswire

Mar. 24, 2026

Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026

Indeterminate GlobeNewswire

Mar. 24, 2026

Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo

Indeterminate GlobeNewswire

Mar. 24, 2026

Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company’s Scientific Advisory Board

Indeterminate GlobeNewswire

Mar. 24, 2026

LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Mar. 24, 2026

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer

Indeterminate GlobeNewswire

Mar. 24, 2026

Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

Indeterminate GlobeNewswire

Mar. 24, 2026

Hyperion DeFi Enters HAUS Agreement with Silhouette

Indeterminate GlobeNewswire

Mar. 24, 2026

Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire

Mar. 24, 2026

Palvella Therapeutics to Host Full Year 2025 Financial Results Conference Call and Provide a Corporate Update on March 31, 2026

Indeterminate GlobeNewswire

Mar. 24, 2026

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Indeterminate GlobeNewswire